Last reviewed · How we verify
BAX 888
At a glance
| Generic name | BAX 888 |
|---|---|
| Also known as | Adeno-associated virus serotype 8 (AAV8) vector expressing B-domain deleted Factor VIII (BDD-FVIII), BAX888 |
| Sponsor | Baxalta now part of Shire |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BAX 888 CI brief — competitive landscape report
- BAX 888 updates RSS · CI watch RSS
- Baxalta now part of Shire portfolio CI